Special Issues and Concerns in the Evaluation of Older Adults Who Have Pain

Clinics in Geriatric Medicine

Volumn 24, Issue 2, 2008, Pages 263-274

  Kirsh, Kenneth L ^a   Smith, Howard S ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADDICTION; AGED; CHRONIC PAIN; DIFFERENTIAL DIAGNOSIS; DRUG ABUSE SCREENING TEST; DRUG DEPENDENCE; HOSPICE; HUMAN; OPIOID RISK TOOL; PAIN ASSESSMENT; PAIN ASSESSMENT AND DOCUMENTATION TOOL; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; SCREENER AND OPIOID ASSESSMENT FOR PATIENTS IN PAIN; SCREENING TEST; SUBSTANCE ABUSE;

AGED; HUMANS; MEDICAL RECORDS; PAIN MEASUREMENT; SUBSTANCE-RELATED DISORDERS;

EID: 41149131872     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2007.12.005     Document Type: Review

References (54)

1. Chelly J.E., Ben-David B., Williams B.A., et al. Anesthesia and postoperative analgesia: outcomes following orthopedic surgery. Orthopedics 26 Suppl 8 (2003) S865-S871
2. Skinner H.B. Multimodal acute pain management. Am J Orthop 33 Suppl 5 (2004) 5-9
3. Carr D.B., and Goudas L.C. Acute pain. Lancet 353 9169 (1999) 2051-2058
4. Dahl J.B., and Møiniche S. Pre-emptive analgesia. Br Med Bull 71 (2004) 13-27
5. Young Casey C., Greenberg M.A., Nicassio P.M., et al. Transition from acute to chronic pain and disability: a model including cognitive, affective, and trauma factors. Pain 134 (2008) 69-79
6. van der Waal J.M., Terwee C.B., van der Windt D.A., et al. Health-related and overall quality of life of patients with chronic hip and knee complaints in general practice. Qual Life Res 14 3 (2005) 795-803
7. Collins J.J., Baase C.M., Sharda C.E., et al. The assessment of chronic health conditions on work performance, absence, and total economic impact for employers. J Occup Environ Med 47 6 (2005) 547-557
8. McCarberg B.H., and Billington R. Consequences of neuropathic pain: quality-of-life issues and associated costs. Am J Manag Care 12 Suppl 9 (2006) S263-S268
9. Griffin R.M. The price tag on pain. WebMD (C.G. Mathis, Reviewer.). Available at:. http://men.webmd.com/features/price-tag-on-pain Accessed May 25, 2007
10. Brems C., Johnson M.E., Wells R.S., et al. Rates and sequelae of the coexistence of substance use and other psychiatric disorders. Int J Circumpolar Health 61 3 (2002) 224-244
11. Passik S.D., Kirsh K.L., Donaghy K.B., et al. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain 22 2 (2006) 173-181
12. Norman S.B., Tate S.R., Anderson K.G., et al. Do trauma history and PTSD symptoms influence addiction relapse context?. Drug Alcohol Depend 90 (2007) 89-96
13. Sullivan M.D., Edlund M.J., Steffick D., et al. Regular use of prescribed opioids: association with common psychiatric disorders. Pain 119 1-3 (2005) 95-103 [Epub 2005 Nov 17]
14. Rosenblum A., Joseph H., Fong C., et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 289 18 (2003) 2370-2378
15. Ramer L., Richardson J.L., Cohen M.Z., et al. Multimeasure pain assessment in an ethnically diverse group of patients with cancer. J Transcult Nurs 10 2 (1999) 94-101
16. Glajchen M., Fitzmartin R.D., Blum D., et al. Psychosocial barriers to cancer pain relief. Cancer Pract 3 2 (1995) 76-82
17. Ward S.E., Goldberg N., Miller-McCauley V., et al. Patient-related barriers to management of cancer pain. Pain 52 (1993) 319-324
18. Joranson D.E., and Gilson A.M. Policy issues and imperatives in the use of opioids to treat pain in substance abusers. J Law Med Ethics 22 3 (1994) 215-223
19. Whitecar P.S., Jonas A.P., and Clasen M.E. Managing pain in the dying patient. Am Fam Physician 61 3 (2000) 755-764
20. SAMHSA. 1999 National Household Survey on Drug Abuse. Substance Abuse and Mental Health Services Administration (SAMHSA) Report Series; 1999.
21. Bruera E., Moyano J., Seifert L., et al. The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage 10 (1995) 599-604
22. Colliver J.D., and Kopstein A.N. Trends in cocaine abuse reflected in emergency room episodes reported to DAWN. Public Health Rep 106 (1991) 59-68
23. Gfroerer J., and Brodsky M. The incidence of illicit drug use in the United States, 1962-1989. Br J Addict 87 (1992) 1345-1351
24. Regier D.A., Farmer M.E., Rae D.S., et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 264 (1990) 2511-2518
25. McCorquodale S., De Faye B., and Bruera E. Palliative care rounds: case report: pain control in an alcoholic cancer patient. J Pain Symptom Manage 8 (1993) 177-180
26. Cook B., and Winokur G. Alcoholism as a family dysfunction. Psychiatr Ann 23 (1993) 508-512
27. Mansky P. Reminiscence of an addictionologist: thoughts of a researcher and clinician. Psychiatr Q 64 (1993) 81-106
28. Passik S.D., and Theobald D.E. Managing addiction in advanced cancer patients: why bother?. J Pain Symptom Manage 19 (2000) 229-234
29. Scham M., and Scham A. Hospices: medical and legal considerations. Leg Med (1985) 297-322
30. Thornton E.S., and Burrow M.A. Possible diversion of pain medication occurs in home hospice setting. Oncol Nurs Forum 23 (1996) 118
31. Hancock C.M. OxyContin use and abuse. Clin J Oncol Nurs 6 2 (2002) 109
32. Gourlay D., and Heit H. Universal precautions: a matter of mutual trust and responsibility. Pain Med 7 2 (2006) 210-211 author reply 212
33. Federation of State Medical Boards of United States, Inc. Model guidelines for the use of controlled substances for the treatment ofpain. 1998. Available at: http://www.fsmb.org. Accessed April 10, 2003.
34. Phillips D.M. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA 284 (2000) 428-429
35. Clark J.D. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 23 (2002) 131-137
36. Solomon D.H., Schaffer J.L., Katz J.N., et al. Can history and physical examination be used as markers of quality? An analysis of the initial visit note in musculoskeletal care. Med Care 38 (2000) 383-391
37. Rhodes D.J., Koshy R.C., Waterfield W.C., et al. Feasibility of quantitative pain assessment in outpatient oncology practice. J Clin Oncol 19 (2001) 501-508
38. Passik S.D., Schreiber J., Kirsh K.L., et al. A chart review of the ordering and documentation of urine toxicology screens in a cancer center: do they influence patient management?. J Pain Symptom Manage 19 (2000) 40-44
39. Brown R.L., and Rounds L.A. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J 94 3 (1995) 135-140
40. Gavin D.R., Ross H.E., and Skinner H.A. Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders. Br J Addict 84 3 (1989) 301-307
41. Akbik H., Butler S.F., Budman S.H., et al. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage 32 3 (2006) 287-293
42. Friedman R., Li V., and Mehrotra D. Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med 4 2 (2003) 182-185
43. Butler S.F., Budman S.H., Fernandez K., et al. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 112 1-2 (2004) 65-75
44. Webster L.R., and Webster R.M. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 6 6 (2005) 432-442
45. Passik S.D., and Weinreb H.J. Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids. Adv Ther 17 (2000) 70-83
46. Passik S.D., Kirsh K.L., Whitcomb L.A., et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther 26 4 (2004) 552-561
47. Passik S.D., Kirsh K.L., Whitcomb L.A., et al. Monitoring outcomes during long-term opioid therapy for non-cancer pain: results with the Pain Assessment and Documentation Tool. J Opioid Manag 1 5 (2005) 257-266
48. Daut R.L., Cleeland C.S., and Flanery R.C. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 17 (1983) 197-210
49. Cleeland C.S., and Ryan K.M. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap 23 (1994) 129-138
50. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1 (1975) 277-299
51. McCarberg B.H., and Barkin R.L. Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther 8 (2001) 181-186
52. Passik S.D., and Portenoy R.K. Substance abuse issues in palliative care. In: Berger A., Portenoy R., and Weissman D. (Eds). Principles and practice of supportive oncology (1998), Lippincott-Raven Publishers, Philadelphia 513-524
53. Passik S.D., Portenoy R.K., and Ricketts P.L. Substance abuse issues in cancer patients part 1: prevalence and diagnosis. Oncology 12 4 (1998) 517-521
54. Khantzian E.J., and Treece C. DSM-III psychiatric diagnosis of narcotic addicts. Arch Gen Psychiatry 42 (1985) 1067-1071